| News Release
Symantec, IBM Launch Anti-Virus Education Program Aimed at Current IBM Customers
Symantec working with IBM Global Services to migrate world's largest companies to Norton AntiVirus
CUPERTINO, Calif --December 21, 1998-- Symantec
Corporation (Nasdaq: SYMC) today announced expansion of its program to educate corporations about
the need to install leading-edge anti-virus software that is updated monthly so that infection from
the latest viruses can be prevented.
The new initiative is targeted at three groups of customers: those who have no anti-virus protection
on their computers now, those who have anti-virus software from IBM, as well as companies using
anti-virus products from Network Associates (Nasdaq: NETA).
The initiative follows the announcement in May that Symantec licensed IBM's immune system technology
and patents and would combine them with its own technology to produce a range of products and
solutions to support IBM platforms. As part of that agreement, IBM assigned its existing anti-virus
customers and OEM contracts to Symantec, and is encouraging its customers who currently have
installed IBM anti-virus software to convert to Symantec's Norton AntiVirus software to get the
monthly virus signature update files that IBM is no longer providing.
More than 3,500 companies, representing approximately two million seats, have committed to
transition from IBM AntiVirus to Norton AntiVirus since the alliance was announced. By working
together, Symantec and IBM Global Services are aiming to help additional customers using IBM
AntiVirus and other anti-virus products make the transition to Norton AntiVirus as well. IBM Global
Services is now recommending Norton AntiVirus to all new customers as its standard anti-virus
solution.
"As IBM and Symantec continue to grow their businesses, a natural next step is to seek out companies
that are not aware of the exposure they have to computer viruses that can shut down their entire
organizations. We also are targeting IBM Global Services customers who haven't converted yet to
Norton AntiVirus, as well as others who use Network Associates' products," said Enrique Salem, vice
president of Symantec's Security and Assistance Business Unit.
"Through our alliance with IBM and purchase of Intel's anti-virus business in September, Symantec
can offer these customers a single solution that incorporates the best technology available to
detect and eliminate viruses across an entire network."
"We will be seeking to educate companies and enterprises of all sizes, regardless of whether they
are using IBM AntiVirus or any other anti-virus product," Salem added. "Most importantly, we're
concerned that a large number of companies have no virus protection today. These companies are at
risk of losing critical data."
George Welyczkowsky, director of technology, service delivery at IBM Global Services, said: "IBM
entered into its alliance with Symantec because we believe Norton AntiVirus is the best product in
the industry and for our customers. Our companies are jointly developing the Norton AntiVirus
technology to provide an even better solution. By helping IBM Global Services' customers migrate to
Norton AntiVirus, we are delivering on our commitment to provide them with the best technology and
service to meet their needs."
About Symantec
Symantec is the world leader in utility software for business and personal computing.
Symantec products and solutions help make users productive and keep their computers
safe and reliable anywhere and anytime. Symantec offers a broad range of solutions
and is acclaimed as a leader in both customer satisfaction and product brand
recognition. Symantec is traded on Nasdaq under the symbol SYMC. More information
on the company and its products can be obtained at www.symantec.com.
NOTE TO EDITORS: If you would like additional information on Symantec Corporation and its products,
view the Symantec Press Center at www.symantec.com/PressCenter/ on Symantec's Website.
Brands and products referenced herein are the trademarks or registered trademarks of their
respective holders. All prices noted are in US dollars and are valid only in the United States.
|